These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


517 related items for PubMed ID: 16918239

  • 1. Trivalent arsenicals are bound to proteins during reductive methylation.
    Naranmandura H, Suzuki N, Suzuki KT.
    Chem Res Toxicol; 2006 Aug; 19(8):1010-8. PubMed ID: 16918239
    [Abstract] [Full Text] [Related]

  • 2. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.
    Hayakawa T, Kobayashi Y, Cui X, Hirano S.
    Arch Toxicol; 2005 Apr; 79(4):183-91. PubMed ID: 15526190
    [Abstract] [Full Text] [Related]

  • 3. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Wang Z, Zhou J, Lu X, Gong Z, Le XC.
    Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
    [Abstract] [Full Text] [Related]

  • 4. Effects of endogenous hydrogen peroxide and glutathione on the stability of arsenic metabolites in rat bile.
    Kobayashi Y, Hirano S.
    Toxicol Appl Pharmacol; 2008 Oct 01; 232(1):33-40. PubMed ID: 18619986
    [Abstract] [Full Text] [Related]

  • 5. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats.
    Suzuki KT, Katagiri A, Sakuma Y, Ogra Y, Ohmichi M.
    Toxicol Appl Pharmacol; 2004 Aug 01; 198(3):336-44. PubMed ID: 15276413
    [Abstract] [Full Text] [Related]

  • 6. Role of the alkali labile sites, reactive oxygen species and antioxidants in DNA damage induced by methylated trivalent metabolites of inorganic arsenic.
    Soto-Reyes E, Del Razo LM, Valverde M, Rojas E.
    Biometals; 2005 Oct 01; 18(5):493-506. PubMed ID: 16333750
    [Abstract] [Full Text] [Related]

  • 7. Metabolic differences between two dimethylthioarsenicals in rats.
    Suzuki KT, Iwata K, Naranmandura H, Suzuki N.
    Toxicol Appl Pharmacol; 2007 Jan 15; 218(2):166-73. PubMed ID: 17174369
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in mice following acute oral administration of arsenate.
    Kenyon EM, Del Razo LM, Hughes MF.
    Toxicol Sci; 2005 May 15; 85(1):468-75. PubMed ID: 15703264
    [Abstract] [Full Text] [Related]

  • 10. Distribution and speciation of arsenic after intravenous administration of monomethylmonothioarsonic acid in rats.
    Naranmandura H, Bu N, Suzuki KT, Lou Y, Ogra Y.
    Chemosphere; 2010 Sep 15; 81(2):206-13. PubMed ID: 20594576
    [Abstract] [Full Text] [Related]

  • 11. Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells.
    Dopp E, Hartmann LM, von Recklinghausen U, Florea AM, Rabieh S, Zimmermann U, Shokouhi B, Yadav S, Hirner AV, Rettenmeier AW.
    Toxicol Sci; 2005 Sep 15; 87(1):46-56. PubMed ID: 15947026
    [Abstract] [Full Text] [Related]

  • 12. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
    Dopp E, Hartmann LM, Florea AM, von Recklinghausen U, Pieper R, Shokouhi B, Rettenmeier AW, Hirner AV, Obe G.
    Toxicol Appl Pharmacol; 2004 Dec 01; 201(2):156-65. PubMed ID: 15541755
    [Abstract] [Full Text] [Related]

  • 13. Tissue distribution and urinary excretion of dimethylated arsenic and its metabolites in dimethylarsinic acid- or arsenate-treated rats.
    Adair BM, Moore T, Conklin SD, Creed JT, Wolf DC, Thomas DJ.
    Toxicol Appl Pharmacol; 2007 Jul 15; 222(2):235-42. PubMed ID: 17559899
    [Abstract] [Full Text] [Related]

  • 14. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.
    Kenyon EM, Hughes MF, Adair BM, Highfill JH, Crecelius EA, Clewell HJ, Yager JW.
    Toxicol Appl Pharmacol; 2008 Nov 01; 232(3):448-55. PubMed ID: 18706920
    [Abstract] [Full Text] [Related]

  • 15. Binding of arsenicals to proteins in an in vitro methylation system.
    Styblo M, Thomas DJ.
    Toxicol Appl Pharmacol; 1997 Nov 01; 147(1):1-8. PubMed ID: 9356301
    [Abstract] [Full Text] [Related]

  • 16. Interaction of trivalent arsenicals with metallothionein.
    Jiang G, Gong Z, Li XF, Cullen WR, Le XC.
    Chem Res Toxicol; 2003 Jul 01; 16(7):873-80. PubMed ID: 12870890
    [Abstract] [Full Text] [Related]

  • 17. Role of glutathione in reduction of arsenate and of gamma-glutamyltranspeptidase in disposition of arsenite in rats.
    Csanaky I, Gregus Z.
    Toxicology; 2005 Feb 01; 207(1):91-104. PubMed ID: 15590125
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro methylation of trivalent and pentavalent arsenicals.
    Styblo M, Yamauchi H, Thomas DJ.
    Toxicol Appl Pharmacol; 1995 Dec 01; 135(2):172-8. PubMed ID: 8545824
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes.
    Vega L, Styblo M, Patterson R, Cullen W, Wang C, Germolec D.
    Toxicol Appl Pharmacol; 2001 May 01; 172(3):225-32. PubMed ID: 11312651
    [Abstract] [Full Text] [Related]

  • 20. Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells.
    Naranmandura H, Ibata K, Suzuki KT.
    Chem Res Toxicol; 2007 Aug 01; 20(8):1120-5. PubMed ID: 17630711
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.